Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:35 PM
Ignite Modification Date:
2025-12-24 @ 5:35 PM
NCT ID:
NCT01817868
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Severe hemophilia A (FVIII\<1%) diagnosis
* Prior treatment or ongoing treatment with on-demand or prophylaxis regimens according to Turkish guidelines and requirements
* Previously treated patients with at least \>50 exposure days
* Written informed consent signed by patient/legal representative
Exclusion Criteria:
* Currently on immune tolerance treatment
* Platelet count \< 75,000/mm3
* Participation in another study
* Existence of inhibitors in the past and in the last currently available blood sample prior to study start (Bethesda titer \< 0.6 BU/ml)
* Existence of inhibitor history in family members who also are diagnosed with hemophilia A
* Having been on primary prophylaxis as defined in the introduction
* Participation in another study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01817868
Study Brief:
Protocol Section:
NCT01817868